Manufacturing standards: Claims of GMP-adjacent manufacturing practices appear in vendor documentation, though research peptide vendors rarely achieve full pharmaceutical GMP certification
Because of the close relationship between risk factors in human metabolism and the expression of GLP-1R in the musculoskeletal system, GLP-1RAs may have great potential in the treatment of many diseases of the musculoskeletal system
Certain individuals, like older adults or women, may be at higher risk of GLP-1 and muscle loss if they arent careful with nutrition
doi: 10.1186/1471-2458-9-88 21 YounossiZM
Landmark trials include STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)